Reinacher-Schick A - Search Results

1

Severe refractory CIDP: a case series of 10 patients treated with bortezomib.

Pitarokoili K, Yoon MS, Kröger I, Reinacher-Schick A, Gold R, Schneider-Gold C. Pitarokoili K, et al. J Neurol. 2017 Sep;264(9):2010-2020. doi: 10.1007/s00415-017-8599-4. Epub 2017 Aug 23. J Neurol. 2017. PMID: 28836002

2

Complete mesocolic excision for right colonic cancer: prospective multicentre study.

Benz SR, Feder IS, Vollmer S, Tam Y, Reinacher-Schick A, Denz R, Hohenberger W, Lippert H, Tannapfel A, Stricker I. Benz SR, et al. Br J Surg. 2022 Dec 13;110(1):98-105. doi: 10.1093/bjs/znac379. Br J Surg. 2022. PMID: 36369986 Free PMC article.

3

Identification of microRNAs in the cerebrospinal fluid as marker for primary diffuse large B-cell lymphoma of the central nervous system.

Baraniskin A, Kuhnhenn J, Schlegel U, Chan A, Deckert M, Gold R, Maghnouj A, Zöllner H, Reinacher-Schick A, Schmiegel W, Hahn SA, Schroers R. Baraniskin A, et al. Blood. 2011 Mar 17;117(11):3140-6. doi: 10.1182/blood-2010-09-308684. Epub 2011 Jan 3. Blood. 2011. PMID: 21200023 Free article.

4

Multiple cerebral infarctions in a young patient with heroin-induced hypereosinophilic syndrome.

Bolz J, Meves SH, Kara K, Reinacher-Schick A, Gold R, Krogias C. Bolz J, et al. J Neurol Sci. 2015 Sep 15;356(1-2):193-5. doi: 10.1016/j.jns.2015.06.031. Epub 2015 Jun 16. J Neurol Sci. 2015. PMID: 26104570

5

Bortezomib Treatment for Patients With Anti-N-Methyl-d-Aspartate Receptor Encephalitis.

Behrendt V, Krogias C, Reinacher-Schick A, Gold R, Kleiter I. Behrendt V, et al. JAMA Neurol. 2016 Oct 1;73(10):1251-1253. doi: 10.1001/jamaneurol.2016.2588. JAMA Neurol. 2016. PMID: 27533122 No abstract available.

6

Amphiphysin-positive paraneoplastic myelitis and stiff-person syndrome.

Faissner S, Lukas C, Reinacher-Schick A, Tannapfel A, Gold R, Kleiter I. Faissner S, et al. Neurol Neuroimmunol Neuroinflamm. 2016 Sep 28;3(6):e285. doi: 10.1212/NXI.0000000000000285. eCollection 2016 Dec. Neurol Neuroimmunol Neuroinflamm. 2016. PMID: 27734022 Free PMC article. No abstract available.

7

Bortezomib in severe MuSK-antibody positive myasthenia gravis: first clinical experience.

Schneider-Gold C, Reinacher-Schick A, Ellrichmann G, Gold R. Schneider-Gold C, et al. Ther Adv Neurol Disord. 2017 Oct;10(10):339-341. doi: 10.1177/1756285617721093. Epub 2017 Jul 26. Ther Adv Neurol Disord. 2017. PMID: 28966662 Free PMC article. No abstract available.

8

Breakthrough treatment with bortezomib for a patient with anti-NMDAR encephalitis.

Schroeder C, Back C, Koc Ü, Strassburger-Krogias K, Reinacher-Schick A, Gold R, Haghikia A. Schroeder C, et al. Clin Neurol Neurosurg. 2018 Sep;172:24-26. doi: 10.1016/j.clineuro.2018.06.005. Epub 2018 Jun 23. Clin Neurol Neurosurg. 2018. PMID: 29960102

9

Prospective Study of the Clinical, Electrophysiologic, and Sonographic Characteristics of Oxaliplatin-Induced Neuropathy.

Pitarokoili K, Höffken N, Lönneker N, Fisse AL, Trampe N, Gold R, Reinacher-Schick A, Yoon MS. Pitarokoili K, et al. J Neuroimaging. 2019 Jan;29(1):133-139. doi: 10.1111/jon.12557. Epub 2018 Sep 10. J Neuroimaging. 2019. PMID: 30198601

10

Dose-dependent immunomodulatory effects of bortezomib in experimental autoimmune neuritis.

Klimas R, Sgodzai M, Motte J, Mohamad N, Renk P, Blusch A, Grüter T, Pedreiturria X, Gobrecht P, Fischer D, Schneider-Gold C, Reinacher-Schick A, Tannapfel A, Yoon MS, Gold R, Pitarokoili K. Klimas R, et al. Brain Commun. 2021 Oct 9;3(4):fcab238. doi: 10.1093/braincomms/fcab238. eCollection 2021. Brain Commun. 2021. PMID: 34708206 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

174 results

Search Page

Filters